-
1
HEMATOLOGICAL PARAMETERS IN THE MODEL OF IRON DEFICIENCY AND HEMATOLOGICAL ANEMIA
Published 2022-12-01Subjects: Get full text
Article -
2
Mega-dose methylprednisolone in hematologic and non-hematological disorders
Published 2010-06-01“…Turkish Journal of Hematology…”
Get full text
Article -
3
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
Published 2023-06-01“…Hematology represents a dynamic specialty in clinical medicine that requires solid knowledge of normal and pathological hematopoiesis, cytomorphology, pathology, immunology, genetics and molecular biology [...]…”
Get full text
Article -
4
Mega-dose methylprednisolone in hematologic and non-hematological disorders
Published 2010-06-01“…Turkish Journal of Hematology…”
Get full text
Article -
5
Hematology and Dermatology /
Published 2012Subjects: “…Hematology…”
Get full text
software, multimedia -
6
-
7
-
8
-
9
Editorial: Case reports in pediatric hematology and hematological malignancies 2022
Published 2023-07-01Subjects: Get full text
Article -
10
Clinical Hematology International: Why a New Journal in Hematology?
Published 2019-03-01“…Clinical Hematology International…”
Get full text
Article -
11
Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
Published 2022-04-01“…Checkpoint inhibitors (CPI) represent a novel therapeutical strategy with a high efficacy both in solid and hematological cancers. They act by reactivating the immune system against neoplastic cells but may, in turn, cause immune-related adverse events (IRAEs) involving several organs with variable frequency and severity. …”
Get full text
Article -
12
COVID-19 in hematology: data from a hematologic and transplant unit
Published 2020-10-01“…Hematology, Transfusion and Cell Therapy…”
Get full text
Article -
13
The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
Published 2022-01-01“…The purpose of this review is to present the current knowledge on the clinical use of several forms of cell therapy in hematological malignancies and the preclinical models available for their study. …”
Get full text
Article -
14
-
15
-
16
-
17
-
18
-
19
-
20